SCHEMBL29685884

SCHEMBL29685884

NC(=O)c1ccc2ncc3cnn(Cc4ccccc4)c3c2c1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ RECQL P46063 1/20 0.43
▸ MMP13 P45452 1/20 0.42
▸ ATM Q13315 1/20 0.41
▸ LMNA P02545 1/20 0.40
▸ ALDH1A1 P00352 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ JAK2 O60674 1/20 0.39
▸ JAK1 P23458 1/20 0.39
▸ TYK2 P29597 1/20 0.39
▸ JAK3 P52333 1/20 0.39
▸ HCAR3 P49019 1/20 0.39
▸ CHEK2 O96017 3/20 0.39
▸ NAMPT P43490 1/20 0.38
▸ EGFR P00533 1/20 0.38
▸ ERBB2 P04626 1/20 0.38
▸ ACSS2 Q9NR19 1/20 0.38
▸ IP6K1 Q92551 1/20 0.38
▸ PTGS1 P23219 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29685139 0.85 LMNA (0.41) RECQLMMP13ATMLMNAALDH1A1
SCHEMBL29685993 0.83 KMT2A (0.42) CHEK2ACSS2
SCHEMBL30971547 0.81 MMP13 (0.41) MMP13ATMLMNAALDH1A1
SCHEMBL30971663 0.79 KMT2A (0.43) JAK2JAK1TYK2JAK3CHEK2
SCHEMBL30661690 0.77 AR (0.45) ALDH1A1KDM4E
SCHEMBL4339555 0.73 LMNA (0.47) RECQLLMNAALDH1A1KDM4ENAMPT
SCHEMBL30642036 0.72 CCNA2 (0.40) CHEK2
SCHEMBL14000509 0.71 RECQL (0.65) RECQLALDH1A1NAMPT
SCHEMBL30971801 0.69 HIF1A (0.38) PTGS1
SCHEMBL6773474 0.68 HCAR3 (0.46) RECQLLMNAALDH1A1KDM4EJAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4251624-A1 TRICYCLIC CARBOXAMIDE DERIVATIVES AS PRMT5 INHIBITORS Amgen, Inc (US) 2023-10-04 — — EP claimed
WO-2022115377-A1 TRICYCLIC CARBOXAMIDE DERIVATIVES AS PRMT5 INHIBITORS AMGEN INC. (US) 2022-06-02 — — WO claimed
EP-4251624-A1 TRICYCLIC CARBOXAMIDE DERIVATIVES AS PRMT5 INHIBITORS Amgen, Inc (US) 2023-10-04 — — EP disclosed
WO-2022115377-A1 TRICYCLIC CARBOXAMIDE DERIVATIVES AS PRMT5 INHIBITORS AMGEN INC. (US) 2022-06-02 — — WO disclosed
Send feedback